CCG215022

Overview

CCG215022 is a G protein-coupled receptor kinases ( GRK s) inhibitor with IC 50 s of 0.15±0.07 μM, 0.38±0.06 μM and 3.9±1 μM for GRK2 , GRK5 and GRK1 , respectively.

Application

Products | Products > Disease Areas > Urogenital Disease | Products > Disease Areas > Cardiovascular Disease | Products > Disease Areas > Prostate Cancer | Products > Disease Areas > Urogenital Cancer | Products > Disease Areas > Pain | Products > Disease Areas > Hypertension | Products > Disease Areas > Cancer | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Signaling Pathways > Stem Cell/Wnt | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > TGF-beta/Smad | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Stem Cells | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > PKA | Products > Signaling Pathways > G Protein-coupled Receptor Kinase (GRK)

Product Information

• Catalog No.: HY-18991
• CAS No.: 1813527-81-9
• Molecular Formula: C26H22FN7O3
• Molecular Weight: 499.50
• Purity: 99.79%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 2.5 mg/mL (5.01 mM); Clear solution
• Availability: In-stock

Source

Original product source